French biotech giant Sanofi is teaming up with Google Life Sciences to develop new products for diabetics monitoring and treatment.
Google is making another move into the profitable sphere of diabetes management: Its Life Sciences arm—which will soon fall under Google's new parent company, Alphabet—is announcing a partnership with Sanofi, a French pharmaceutical company, to build new treatment products for diabetes. The two firms will collaborate on product development and new methods for monitoring the condition.